Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001562180-24-001995

SVP, Chief Legal Officer sold 7,411 shares at $1.52 ($11,265)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Hadas Nicole R. · SVP, Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-27 Sale : show line 1 in the form 10b5-1 −7,411 $1.52 $11,265 669,233 D
Open-market sales · 7,411 sh · avg $1.52 · $11,265
Loading xslF345X05/primarydocument.xml…